Maze Therapeutics, Inc.
- MAZE
- NASDAQ
- Biotechnology
- Precision Medicine (Small Molecule)
- Kidney/Metabolic Diseases
$27.53
Today +0.18%Quote Oct 16, 2026, 08:00 PM UTC
+17.45%over the last month
Max drawdown −8.8%From 1-month high −3.0%3 months −3.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.53B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$54.13
+96.6% from here
Floor
$27.20
1.2% below price
Where the price sits
6 analysts
Analyst range, low to high
$17.00$97.00
- Price $27.53
- Resistance $27.85
- Consensus $54.13
The price is just above its floor and right under resistance. Analysts' average target sits about 97% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MAZEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
141
Founded
2017